- Mindfulness-based stress reduction (MBSR) reduces anxiety and depression in peri- and postmenopausal women despite no reduction in somatic symptoms.
Why this matters
- Some studies suggest that women's psychological responses to vasomotor and somatic symptoms of menopause may exacerbate physical symptoms.
- Mindfulness-based therapies have been effective in improving psychological and physical outcomes in a variety of clinical settings.
- MBSR may help reduce the need for pharmacologic treatment of menopausal symptoms.
- A reduction in Greene Climacteric Scale (GCS) score at 6 months after intervention was seen in both groups.
- Women in the MBSR group had lower GCS scores compared with women in the menopause education control group (mean difference, −3.27 [−5.51 to −1.03; P=.005]).
- There was a significant reduction in anxiety and depression symptoms in the MBSR group; somatic, urogenital, and vasomotor symptoms were not reduced.
- Randomized controlled trial of perimenopausal and menopausal women aged 40-60 years who were recruited through advertisement and emails.
- Women were randomly assigned to a MBSR program (n=98) vs a menopause education control group (n=99).
- Primary outcomes included GCS scores 6 months after intervention.
- Funding: None disclosed.
- Self-selection bias possible.
- Results may not be generalizable.